mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.2 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
-0.07 |
0.2 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.074 |
0.2 |
mRNA |
Pazopanib |
GDSC1000 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.2 |
mRNA |
BRD-K33199242 |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.2 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.2 |
mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |